PURPOSE: We describe a method for analysis of [11C]flumazenil data using an input curve directly derived from the positron emission tomography (PET) images. PROCEDURE: The shape of the tracer plasma curve was obtained from the product of the intact flumazenil fraction in plasma in six arterial samples and the internal carotid artery time-activity curve (TAC). The resulting curve was calibrated using the [11C]flumazenil concentration in three of the six samples. The curve peak was recovered by adding an exponential function to the scaled curve whose parameters were estimated from simultaneous fittings of several tissue TACs assuming that all regions share the same input. RESULTS: Good agreement was found between the image-derived and the experimental plasma curves in six subjects. Distribution volumes were highly correlated with linear regression slope and intercept values between [0.94, 1.03] and [-0.10, 0.16], respectively. CONCLUSION: The proposed method is suitable for benzodiazepine receptor quantification requiring only a few blood samples.
PURPOSE: We describe a method for analysis of [11C]flumazenil data using an input curve directly derived from the positron emission tomography (PET) images. PROCEDURE: The shape of the tracer plasma curve was obtained from the product of the intact flumazenil fraction in plasma in six arterial samples and the internal carotid artery time-activity curve (TAC). The resulting curve was calibrated using the [11C]flumazenil concentration in three of the six samples. The curve peak was recovered by adding an exponential function to the scaled curve whose parameters were estimated from simultaneous fittings of several tissue TACs assuming that all regions share the same input. RESULTS: Good agreement was found between the image-derived and the experimental plasma curves in six subjects. Distribution volumes were highly correlated with linear regression slope and intercept values between [0.94, 1.03] and [-0.10, 0.16], respectively. CONCLUSION: The proposed method is suitable for benzodiazepine receptor quantification requiring only a few blood samples.
Authors: Sandra Marina Sanabria-Bohórquez; Terence G Hamill; Karolien Goffin; Inge De Lepeleire; Guy Bormans; H Donald Burns; Koen Van Laere Journal: Eur J Nucl Med Mol Imaging Date: 2009-12-24 Impact factor: 9.236
Authors: N Kudomi; L Slimani; M J Järvisalo; J Kiss; R Lautamäki; G A Naum; T Savunen; J Knuuti; H Iida; P Nuutila; P Iozzo Journal: Eur J Nucl Med Mol Imaging Date: 2008-05-06 Impact factor: 9.236
Authors: Paolo Zanotti-Fregonara; Jeih-San Liow; Claude Comtat; Sami S Zoghbi; Yi Zhang; Victor W Pike; Masahiro Fujita; Robert B Innis Journal: Nucl Med Commun Date: 2012-09 Impact factor: 1.690
Authors: Shouyi Wei; Nandita Joshi; Michael Salerno; David Ouellette; Lemise Saleh; Christine DeLorenzo; Craig Woody; David Schlyer; Martin L Purschke; Jean-Francois Pratte; Sachin Junnarkar; Michael Budassi; Tuoyu Cao; Jack Fried; Joel S Karp; Paul Vaska Journal: IEEE Trans Radiat Plasma Med Sci Date: 2021-09-13
Authors: N Kudomi; M J Järvisalo; J Kiss; R Borra; A Viljanen; T Viljanen; T Savunen; J Knuuti; H Iida; P Nuutila; P Iozzo Journal: Eur J Nucl Med Mol Imaging Date: 2009-12 Impact factor: 9.236